Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	825.94	714.73	582.02	437.86	305.44	159.74
Revenue Growth (YoY)	21.13%	22.80%	32.93%	43.35%	91.21%	2564.59%
Cost of Revenue	184.21	156.82	121.24	83.48	55.52	27.74
Gross Profit	641.74	557.92	460.79	354.37	249.92	132
Selling, General & Admin	241.77	221.27	192.69	163.3	132.03	95.57
Research & Development	174.33	145.83	76.06	70.89	30.37	19.45
Operating Expenses	416.1	367.09	268.76	234.19	162.39	115.02
Operating Income	225.64	190.83	192.03	120.19	87.53	16.99
Interest Expense	-15.31	-17.5	-23.76	-18.8	-24.19	-28.62
Interest & Investment Income	20.55	18.54	14.73	3.13	0.22	0.4
Other Non Operating Income (Expenses)	-0.42	-0.07	0.16	0.17	0.02	-3.07
EBT Excluding Unusual Items	230.46	191.8	183.16	104.69	63.57	-14.31
Other Unusual Items	-	-	-9.77	-	-26.15	-22.64
Pretax Income	230.46	191.8	173.4	104.69	37.43	-36.94
Income Tax Expense	44.78	46.31	44.54	-76.78	2.83	-
Net Income	185.68	145.49	128.85	181.47	34.6	-36.94
Preferred Dividends & Other Adjustments	-	-	-	-	-	26.9
Net Income to Common	185.68	145.49	128.85	181.47	34.6	-63.85
Net Income Growth	51.42%	12.91%	-28.99%	424.52%	-	-
Shares Outstanding (Basic)	58	57	59	59	58	26
Shares Outstanding (Diluted)	59	58	60	61	59	26
Shares Change (YoY)	1.02%	-4.15%	-1.19%	3.19%	129.72%	231.37%
EPS (Basic)	3.23	2.56	2.17	3.07	0.60	-2.48
EPS (Diluted)	3.17	2.51	2.13	2.97	0.58	-2.48
EPS Growth	50.44%	17.84%	-28.28%	412.07%	-	-
Free Cash Flow	296.89	218.67	219.08	144.29	98.26	-2.99
Free Cash Flow Per Share	5.07	3.78	3.63	2.36	1.66	-0.12
Gross Margin	77.70%	78.06%	79.17%	80.93%	81.82%	82.64%
Operating Margin	27.32%	26.70%	32.99%	27.45%	28.66%	10.63%
Profit Margin	22.48%	20.36%	22.14%	41.45%	11.33%	-39.97%
Free Cash Flow Margin	35.95%	30.59%	37.64%	32.95%	32.17%	-1.87%
EBITDA	249.51	214.94	216.39	143.57	106.37	27.22
EBITDA Margin	30.21%	30.07%	37.18%	32.79%	34.83%	17.04%
D&A For EBITDA	23.87	24.11	24.36	23.39	18.84	10.24
EBIT	225.64	190.83	192.03	120.19	87.53	16.99
EBIT Margin	27.32%	26.70%	32.99%	27.45%	28.66%	10.63%
Effective Tax Rate	19.43%	24.14%	25.69%	-	7.56%	-
Advertising Expenses	-	27.56	21.54	22.43	19.56	13.3

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q